NCT06305104View on ClinicalTrials.gov

Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.

PHASE2RecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

June 30, 2024

Conditions
Tuberculosis
Interventions
BIOLOGICAL

2.5μg/ml EEC

0.1ml ,one time, containing low dose of 2.5μg/ml of active ingredients

BIOLOGICAL

5μg/ml EEC

0.1ml, one time, containing high dose 5μg/ml of active ingredients

BIOLOGICAL

5 unit（U） EC

0.1 ml , one time, containing 5U of active ingredients

Trial Locations (6)

101149

RECRUITING

Beijing Chest Hospital, Beijing

212400

RECRUITING

Jiangsu Province Centers for Disease Control and Prevention, Nanjing

415000

RECRUITING

Changde First People's Hospital, Changde

430000

RECRUITING

Wuhan Institute for Tuberculosis Control, Wuhan

610066

RECRUITING

Public health clinical center of chengdu, Chengdu

Unknown

RECRUITING

Xuzhou Infectious Disease Hospital, Xuzhou

All Listed Sponsors
collaborator

Beijing Chest Hospital, Capital Medical University

OTHER

collaborator

Wuhan Institute for Tuberculosis Control

OTHER

collaborator

The Public Health Clinical Center of Chengdu

UNKNOWN

collaborator

Xuzhou Infectious Disease Hospital

UNKNOWN

collaborator

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

collaborator

Changde First People's Hospital

UNKNOWN

lead

Chengdu CoenBiotech Co., Ltd

INDUSTRY